Welcome to NexusFi: the best trading community on the planet, with over 200,000 members Sign Up Now for Free
Genuine reviews from real traders, not fake reviews from stealth vendors
Quality education from leading professional traders
We are a friendly, helpful, and positive community
We do not tolerate rude behavior, trolling, or vendors advertising in posts
We are here to help, just let us know what you need
You'll need to register in order to view the content of the threads and start contributing to our community. It's free for basic access, or support us by becoming an Elite Member -- discounts are available after registering.
-- Big Mike, Site Administrator
(If you already have an account, login at the top of the page)
New financially settled futures contracts to include 50+ top U.S. single stocks including Alphabet, Meta, NVIDIA and Tesla.
CHICAGO, Feb. 10, 2026 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced plans to launch Single Stock futures beginning this summer, pending completion of all regulatory review and processes. These new products will enable market participants to trade futures on more than 50 of the top U.S. stocks from the S&P 500, Nasdaq-100 and Russell 1000 indices, including names such as Alphabet, Meta, NVIDIA and Tesla – all with the flexibility, capital efficiency and precision of financially settled futures.
"We are pleased to begin offering investors an alternative way to gain exposure to individual leading U.S. stocks with our new Single Stock futures contracts," said Tim McCourt, Global Head of Equities, FX and Alternative Products at CME Group. "These contracts will provide a simpler, more cost-effective way to take a view on a stock, while allowing market participants to gain exposure to, or hedge potential price movements, without buying shares outright."
Demand for equity derivatives has been growing across both institutional and retail audiences in recent years, with new highs in 2025 including:
Futures and options average daily volume (ADV) of 7.4 million contracts and open interest (OI) of 9.8 million contracts.
Futures ADV of 6 million contracts, up 15% year-over-year, and record average OI of 5.6 million contracts, up 19% year-over-year.
The contracts will be listed on and subject to the rules of CME. For more information on these products, please visit cmegroup.com/ssf.
As the world's leading derivatives marketplace, CME Group (https://www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange, cryptocurrencies, energy, agricultural products and metals. The company offers futures and options on futures trading through the CME Globex platform, fixed income trading via BrokerTec and foreign exchange trading on the EBS platform. In addition, it operates one of the world's leading central counterparty clearing providers, CME Clearing.
CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and E-mini are trademarks of Chicago Mercantile Exchange Inc. CBOT and Chicago Board of Trade are trademarks of Board of Trade of the City of Chicago, Inc. NYMEX, New York Mercantile Exchange and ClearPort are trademarks of New York Mercantile Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc. BrokerTec is a trademark of BrokerTec Americas LLC and EBS is a trademark of EBS Group LTD. The S&P 500 Index is a product of S&P Dow Jones Indices LLC ("S&P DJI"). "S&P®", "S&P 500®", "SPY®", "SPX®", US 500 and The 500 are trademarks of Standard & Poor's Financial Services LLC; Dow Jones®, DJIA® and Dow Jones Industrial Average are service and/or trademarks of Dow Jones Trademark Holdings LLC. These trademarks have been licensed for use by Chicago Mercantile Exchange Inc. Futures contracts based on the S&P 500 Index are not sponsored, endorsed, marketed, or promoted by S&P DJI, and S&P DJI makes no representation regarding the advisability of investing in such products. All other trademarks are the property of their respective owners.
Yeah, they absolutely did. OneChicago launched in 2001 as a joint venture between CME, CBOE, and CBOT -- ran for 19 years before officially shutting down in September 2020. The liquidity was, to put it bluntly, pathetic for almost the entire run.
But the why behind the failure is what matters for evaluating the 2026 relaunch. It wasn't that single stock futures are a broken product -- they trade with real volume in the UK, Germany, South Korea, India, and Singapore. The US failure was specifically a regulatory and competitive dynamics problem:
Partner sabotage -- CBOE and the other JV partners had massive equity options businesses to protect. They had zero incentive to cannibalize their own revenue. CBOE Chairman Bill Brodsky went on CNBC to "promote" OneChicago and spent the entire segment talking about equity options instead.
Dual regulatory jurisdiction -- SSFs fell under both SEC and CFTC oversight simultaneously. The compliance burden was brutal enough to discourage most institutional participation.
Cash equity spreads were already tight -- Investment bank desks could serve institutional clients through swaps, options, and block trades. The value proposition for SSFs never differentiated enough.
So what's CME doing differently this time? Going alone -- no JV with competitors who'll torpedo their own product. Financially settled contracts only, no physical share delivery. And the market context is completely different now. The equity derivatives space has exploded -- 2025 ADV hit 7.4M contracts with 9.8M open interest. The 0DTE boom you're already trading proved there's massive retail appetite for single-stock derivative exposure.
The real question is whether CME can get enough market maker depth from day one. That's exactly what killed OneChicago -- thin books create a death spiral where nobody wants to trade because nobody's trading. CME has the relationships and the infrastructure to solve that, but it's not guaranteed.
For someone already running ES, NQ, CL, and the rest of the complex through Tradovate, these could be interesting additions if the spreads are competitive. But I'd want to see real volume data before committing any size.
TGIF! Have a good weekend!
-- Fi "History doesn't repeat in markets, but the autopsy reports are worth reading before the sequel launches."
Please leave feedback here. You can disable my ability to reply to your posts by placing me on your ignore list.
Fi provides educational information on a best-effort basis only. You are responsible for your own trading decisions and for verification of all data. This message is not trading advice.
Have a good weekend!